<DOC>
	<DOCNO>NCT02798757</DOCNO>
	<brief_summary>This phase IV study explore mechanisms action drug ( dapagliflozin ) already commercially available country study conduct ( Greece ) . The drug use accord approved clinical indication ( add-on treatment patient fail achieve glycemic target metformin monotherapy ) approve posology ( 10 mg/day ) . Additionally , although limit data coadministration dapagliflozin thiazide , excellent safety profile drug even use combination drug induce significant volume depletion ( loop diuretic ) suggest , properly select patient , possibility important adverse event coadministration dapagliflozin chlorthalidone low . All patient give write informed consent prior enrollment study . The study protocol approve scientific committee University Hospital Ioannina .</brief_summary>
	<brief_title>Evaluation Tubular Effects Dapagliflozin Using 1HNMR Spectroscopy</brief_title>
	<detailed_description>Fifty patient type 2 diabetes metformin monotherapy HbA1c &gt; 7 % blood pressure &gt; 140/90 mmHg include . All eligible patient give dapagliflozin 10 mg qd 3 month . Routine laboratory parameter measure visit include : 1 ) serum sample : glucose , urea , creatinine , uric acid , electrolytes ( sodium , potassium , chloride , calcium , phosphate magnesium 2 ) urine sample : glucose , urea , creatinine , uric acid , electrolytes ( sodium , potassium , chloride , calcium , phosphate magnesium ) alpha-1 microglobulin . It well know alpha-1 microglobulin low-molecular weight protein normally filter renal glomerulus reabsorb proximal tubular cell . Increased excretion alpha1-microglobulin propose non-invasive marker diagnosis monitor early tubular disorder diabetic nephropathy . In addition , fractional excretion value ( FE ) electrolytes calculated use formula : FEA ( % ) = ( UrineA/SerumA ) / ( UrineCr/SerumCr ) × 100 . The 1HΝMR spectra urine sample record 500 MHz spectrometer . In present study , main low molecular weight ( LMW ) constituent urine quantify 1 ) metabolite glucose , creatinine , creatine , choline , taurine , dimethylamine , betaine , trimethylaminoxide 2 ) amino acid glycine , valine , alanine , leucine , histidine , lysine , threonine 3 ) organic acid citrate , hippurate , lactate , acetate , succinate , formate . In addition , 1HNMR methodology allow detection change concentration hundred metabolite . These substance normally present trace , whereas pathological condition concentration find increase .</detailed_description>
	<criteria>1 . Provision inform consent prior study specific procedures 2 . Female and/or male age 1870 year . Women childbearing potential include study serological pregnancy test negative safe contraception method use throughout study . 3 . Uncontrolled type 2 diabetes mellitus ( HbA1c &gt; 7 % ) metformin monotherapy ( ≥ 2000 mg qd maximum tolerate dose ) 4 . Stage 1 hypertension ( BP 140159/9099 mmHg ) 1 . Known primary kidney disease ( eGFR &lt; 60 ml/min ) 2 . History cardiovascular disease 3 . Type 1 diabetes 4 . History heart failure 5 . Diseases shorten life expectancy ( cancer , degenerative neurological disorder etc . ) 6 . Pregnancylactation 7 . Patients eGFR value low 45 ml/min ( repeat measurement ) study period exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>